CD274 and non-small cell lung carcinoma: However, a significant survival benefit compared with chemotherapy alone even in PD‐L1 low or negative expression advanced NSCLC was observed in combination therapy, but it was associated with a higher incidence of grade ≥ 3 TRAEs.